For the first time in the world, Kawasaki Institute of Industrial Promotion Innovation Center of NanoMedicine (Director General: Kazunori Kataoka, Location: Kawasaki-ku Kawasaki City, Abbreviation: iCONM) has succeeded in controlling the clearance of gene therapy drugs at the liver sinusoidal wall by developing a reagent for the Selective and transient coating of the liver sinusoidal walls. This was collaborative research with Dr. Kensuke Osada from the National Institute for Quantum Science and Technology, (Director: Toshio Hirano, Location: Chiba City Chiba Pref., Abbreviation: QST）and Dr. Satoshi Uchida from Department of Bioengineering, Graduate School of Engineering, The University of Tokyo.

The result of this research was published in Science Advances (Impact Factor=12.804) issued by AAAS.

At the press conference held online on Friday, June 26, Kazunori Kataoka, Director General, Innovation Center of NanoMedicine; Satoshi Uchida, Assistant Professor, Department of Bioengineering, Graduate School of Engineering, The University of Tokyo; Dirisala Anjaneyulu, Research Scientist, Innovation Center of NanoMedicine; Kensuke Osada, Senior Researcher, National Institutes for Quantum and Radiological Science and Technology; participated in the session, and there were deep and insightful discussions with journalists from the science department of general newspapers, and bio journals.